A randomized trial of intravenous iloprost (a stable prostacyclin analogue) versus lumbar sympathectomy in the management of Buerger's disease

International Angiology

Volumn 25, Issue 2, 2006, Pages 162-168

  Bozkurt, A Kursat ^a,m   Koksal C ^b   Demirbas, M Y ^a   Erdogan A ^c   Rahman, A ^d   Demirkilic U ^e   Ustunsoy H ^f   Metin, G ^g   Yillik, L ^h   Onol H ⁱ   Cinar B ^j   Karacelik M ^k   Erdinc I ^l   Bolcal, C ^e   Sayin, A G ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Sureyyapasa Thorax and Cardiovascular Diseses Training Hospital   (Turkey)

^c AKDENIZ UNIVERSITY   (Turkey)

^d FIRAT UNIVERSITY   (Turkey)

^e GULHANE SCHOOL OF MEDICINE   (Turkey)

^f GAZIANTEP UNIVERSITY   (Turkey)

^g Department of Ophthalmology   (Turkey)

^h ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

ⁱ Alsancak State Hospital   (Turkey)

^j DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^k Tepecik Training and Research Hospital   (Turkey)

^l Izmir Research and Training Hospital   (Turkey)

^m Department of Cardiovascular Surgery ^*  (Turkey)

more..

Author keywords

Buerger's disease; Iloprost; Lumbar sympathectomy; Prostacyclin analogues, and derivates; Prostaglandins; Thromboangiitis obliterans, surgery

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ILOPROST; PROSTACYCLIN DERIVATIVE;

ADULT; AGED; AMPUTATION; ARTICLE; BUERGER DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEALING; HEALTH STATUS; HUMAN; INTERMETHOD COMPARISON; ISCHEMIA; LUMBAR SYMPATHECTOMY; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; PAIN; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RELIABILITY; REST; STATISTICAL SIGNIFICANCE; ULCER;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; ILOPROST; INJECTIONS, INTRAVENOUS; LUMBOSACRAL PLEXUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SYMPATHECTOMY; THROMBOANGIITIS OBLITERANS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 33745913283     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Olin JW: Thromboangiitis obliterans (Buerger's disease). In: Rutherford RB, editor. Vascular surgery, 6th ed. Philadelphia: WB Saunders Co; 2005.p.404-19.
2. Sayin A, Bozkurt AK, Tuzun H, Vural FS, Erdog G, Ozer M. Surgical treatment of Buerger's disease: experience with 216 patients. Cardiovasc Surg 1993;1:377-80.
3. Bozkurt AK, Besirli K, Koksal C, Sirin G, Yüceyar L, Tuzun H et al. Surgical treatment of Buerger's disease. Vascular 2004;12:192-7.
4. Shionoya S. Buerger's disease (thromboangiitis obliterans). In: Rutherford RB, editor. Vascular surgery, 3rd ed. Philadelphia: WB Saunders Co; 1989.p.207-17.
5. Ohta T, Ishioashi H, Hosaka M, Sugimoto I. Clinical and social consequences of Buerger's disease. J Vasc Surg 2004;39:176-80.
6. Sasajima T, Kubo Y, Inaba M, Goh K. Role of infrainguinal bypass in Buerger's disease: an eighteen-year experience. Fur J Vasc Endovasc Surg 1997;13:186-92.
7. Dilege S, Aksoy M, Kayabali M, Gene FA, Senturk M, Baktiroglu S. Vascular reconstruction in Buerger's disease: is it feasible? Surg Today 2002;32:1042-7.
8. Shindo S, Matsumoto H, Ogata K, Kubota K, Kojima A, Ishimoto T et al. Arterial reconstruction in Buerger's disease: by-pass to disease-free collaterals. Int Angiol 2002;21:228-32.
9. Parmer S, Mitchell M. Buerger's disease (thromboangiitis obliterans). In: Rajagopalan S, Mukherjee D, Mohler E, editors. Manual of vascular diseases. Philadelphia: Lippincott Williams and Wilkins; 2005.p.112-9.
10. Olin JW. Thromboangiitis obliterans (Buerger's disease). N Engl J Med 2000;343:864-9.
11. Gordon A, Zechmeister K, Collin J. The role of sympathectomy in current surgical practice. Eur J Vasc Surg 1994;8:129-37.
12. Van Damme H, De Leval L, Creemers E, Limet R, Thrombangiitis obliterans (Buerger's disease): still a limb threatening disease. Acta Chir Belg 1997;97:229-36.
13. Lau H, Cheng SW. Buerger's disease in Hong Kong: a review of 89 cases. Aust N Z J Surg 1997;67:264-9.
14. al Zahrani HA. Arteritis: experience in Jeddah, Saudi Arabia. Cardiovasc Surg 1993;1:215-9.
15. Benyahia B, Bensaid Y, Ammar F, Dhobb M, Benjelloun A, Benabderrazik T. Arteriopathies of the lower limbs in adults under 40 years of age. Chirurgie 1989;115 Suppl 1:18-26.
16. Singh I, Ramteke VK. The role of omental transfer in Buerger's disease: New Delhi's experience. Aust N Z J Surg 1996;66:372-6.
17. Talwar S, Jain S, Porwal R, Laddha BL, Prasad P. Free versus pedicled omental grafts for limb salvage in Buerger's disease. Aust N Z J Surg 1998;68:38-40.
18. Fiessinger IN, Schafer M. Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study. Lancet 1990;335:555-7.
19. Melian EB, Goa KL. Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension. Drugs 2002;62:107-33.
20. Poredos P. Possibilities for clinical use of prostacyclin in vascular disease. Pflugers Arch 2000;440(5 Suppl): R137-8.
21. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997;26:517-38.
22. Kalani M, Apelqvist J, Blomback M, Brismar K, Eliasson B, Eriksson JW et al. Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study. Diabetes Care 2003;26:2575-80.
23. Cabezas-Moya R, Dragstedt LR. An extreme example of Buerger's disease. Arch Sing 1970;101:632-4.
24. 99mTc-tetrofosmin (TF) perfusion scintigraphy Cell Transplant 2004;13:429-37.
25. Morishita R, Aoki M, Hashiya N, Makino H, Yamasaki K, Azuma J et al. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 2004;44:203-9.
26. Donas KP, Schulte S, Ktenidis K, Horsch S. The role of epidural spinal cord stimulation in the treatment of Buerger's disease. J Vasc Surg 2005;41:830-6.
27. Swigris JJ, Olin JW, Mekhail NA. Implantable spinal cord stimulator to treat the ischemic manifestations of thromboangiitis obliterans (Buerger's disease). J Vasc Surg 1999;29:928-35.
28. The European TAO Study Group. Oral iloprost in the treatment of thromboangiitis obliterans (Buerger's disease): a double-blind, randomised, placebo-controlled trial. Eur J Vasc Endovasc Surg 1998;15:300-7.
29. Matsushita M, Nishikimi N, Sakurai T, Nimura Y. Decrease in prevalence of Buerger's disease in Japan. Surgery 1998;124:498-502.
30. Nakajima N. The change in concept and surgical treatment on Buerger's disease: personal experience and review. Int J Cardiol 1998;66 Suppl 1:S273-S280.
31. Higman DJ, Strachan AM, Buttery L, Hicks RC, Springall DR, Greenhalgh RM et al. Smoking impairs the activity of endothelial nitric oxide synthase in saphenous vein. Arterioscler Thromb Vasc Biol 1996;16:546-52.
32. Brodmann M, Lischnig U, Lang B, Lueger A, Pilger E, Stark G. The evaluation of the no-independent vasodilatative effect of iloprost in isolated perfused Guinea pig hind limbs. Int Angiol 2004;23:72-5.